Introducing the drug Leango-var
Weekly injections of Leango-var (containing tirzepatide) help reduce and maintain excess body weight in adults with obesity, or in some individuals with overweight and related medical conditions, when combined with diet and physical activity. By activating GIP and GLP-1 receptors, it helps decrease appetite, support weight control, and improve blood glucose management in people with Type 2 diabetes.
Leango-var may also support the management of conditions associated with obesity, including obstructive sleep apnea, non-alcoholic fatty liver disease, and polycystic ovary syndrome. It is a tirzepatide brand that is fully comparable to the reference brands Mounjaro and Zepbound, including the active ingredient and injection device.
In this section, you can learn about the mechanism of action, indications, warnings and precautions, possible side effects and their management, as well as available support programs, and read about patient experiences with this therapy.
Enhances the feeling of fullness
Reduces the urge to overeat
Supports gradual and sustainable weight control
“Having access to consultation reduced my concerns throughout the treatment process.”
“Being able to ask my questions helped me stay more consistent with my treatment.”
“The sense of support throughout treatment made my experience completely different.”
“The educational resources and explanations helped me start my treatment with greater confidence.”
